Viral-based nanomaterials for plasmonic and photonic materials and devices.
Sign Up to like & getrecommendations! Published in 2018 at "Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology"
DOI: 10.1002/wnan.1508
Abstract: Over the last decade, viruses have established themselves as a powerful tool in nanotechnology. Their proteinaceous capsids benefit from biocompatibility, chemical addressability, and a variety of sizes and geometries, while their ability to encapsulate, scaffold,… read more here.
Keywords: photonic materials; viral based; plasmonic photonic; nanomaterials plasmonic ... See more keywords
The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma–Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses
Sign Up to like & getrecommendations! Published in 2017 at "Current Neurology and Neuroscience Reports"
DOI: 10.1007/s11910-017-0754-x
Abstract: Purpose of ReviewMalignant gliomas, including glioblastoma and anaplastic astrocytoma, are the most frequent primary brain tumors and present with many treatment challenges. In this review, we discuss the potential of cellular- and viral-based immunotherapies in… read more here.
Keywords: viral based; malignant glioma; cellular viral; cell vaccines ... See more keywords
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
Sign Up to like & getrecommendations! Published in 2017 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-017-0274-x
Abstract: BackgroundAdvanced non-small cell lung cancer patients receiving TG4010, a therapeutic viral vaccine encoding human Mucin 1 and interleukin-2 in addition to standard chemotherapy, displayed longer overall survival in comparison to that of patients treated with… read more here.
Keywords: viral based; based vaccine; response; tg4010 ... See more keywords